宠物治疗饮食市场－全球产业规模、份额、趋势、机会和预测，按产品、动物类型、适应症、配销通路、地区和竞争细分，2020-2030 年

2024 年全球宠物治疗性饮食市场价值为 24.5 亿美元，预计到 2030 年将达到 37 亿美元，预测期内的复合年增长率为 7.10%。全球宠物治疗性饮食市场正在经历强劲增长，这得益于宠物拥有量增加、宠物人性化程度提高以及肥胖、糖尿病、肾臟疾病和胃肠道疾病等慢性健康状况日益普遍。宠物主人越来越多地寻求兽医推荐的专业饮食，以提供针对特定情况的营养和整体健康益处。干粮因其方便、保质期长和牙齿健康益处仍然是主要形式，而狗由于数量较多和饮食需求多样化而占据市场主导地位。北美引领市场，得益于高宠物拥有量、强大的消费者意识以及完善的兽医和分销网络。

市场概况
预测期	2026-2030
2024年市场规模	24.5亿美元
2030年市场规模	37亿美元
2025-2030年复合年增长率	7.10%
成长最快的领域	猫
最大的市场	北美洲

影响市场的关键趋势包括功能性成分的整合、个人化营养、可持续且符合道德标准的饮食、宠物护理的技术创新以及电子商务和兽医管道的拓展。儘管成长潜力巨大，但诸如治疗性饮食的高昂成本、监管的复杂性、部分地区认知度有限以及适口性问题等挑战可能会限制市场扩张。总体而言，随着宠物主人越来越重视宠物的健康和福祉，市场有望持续成长。

关键市场驱动因素

宠物慢性疾病盛行率上升

主要市场挑战

治疗性饮食成本高昂

主要市场趋势

功能性成分的整合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球宠物治疗饮食市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（湿粮、干粮、其他）
  • 依动物类型（狗、猫、其他）
  • 按适应症（肾臟护理、肥胖护理、糖尿病护理、牙科护理、胃肠道护理、復健护理、其他）
  • 按配销通路（电子商务、兽医院和诊所、零售药局、其他）
  • 按地区
  • 按公司分类（2024 年）
• 市场地图

第六章：北美宠物治疗饮食市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲宠物治疗饮食市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太宠物治疗饮食市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲宠物治疗饮食市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲宠物治疗饮食市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：全球宠物治疗饮食市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
• Nestle SA
• Mars, Incorporated
• General Mills Inc. (Blue Buffalo Company, Ltd.)
• SCHELL & KAMPETER, INC. (DIAMOND PET FOODS)
• Virbac Corporation
• Veterinary Nutrition Group Pty Ltd
• Farmina Pet Foods
• JustFoodForDogs
• EmerAid, LLC

第 16 章：策略建议

第17章调查会社について・免责事项

Global Pet Therapeutic Diet Market was valued at USD 2.45 Billion in 2024 and is expected to reach USD 3.70 Billion by 2030 with a CAGR of 7.10% during the forecast period. The global pet therapeutic diet market is experiencing robust growth, driven by rising pet ownership, increasing humanization of pets, and the growing prevalence of chronic health conditions such as obesity, diabetes, kidney disease, and gastrointestinal disorders. Pet owners are increasingly seeking specialized, veterinary-recommended diets that provide condition-specific nutrition and overall wellness benefits. Dry food remains the leading format due to its convenience, long shelf life, and dental health benefits, while dogs dominate the market owing to their larger population and diverse dietary requirements. North America leads the market, supported by high pet ownership, strong consumer awareness, and well-established veterinary and distribution networks.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.45 Billion
Market Size 2030	USD 3.70 Billion
CAGR 2025-2030	7.10%
Fastest Growing Segment	Cats
Largest Market	North America

Key trends shaping the market include the integration of functional ingredients, personalized nutrition, sustainable and ethically sourced diets, technological innovations in pet care, and expansion of e-commerce and veterinary channels. Despite high growth potential, challenges such as the premium cost of therapeutic diets, regulatory complexities, limited awareness in some regions, and palatability issues may constrain market expansion. Overall, the market is poised for continued growth as pet owners increasingly prioritize the health and well-being of their animals.

Key Market Drivers

Rising Prevalence of Chronic Health Conditions in Pets

The increasing prevalence of chronic health conditions in pets is a significant driver of the global pet therapeutic diet market. As pets live longer and human-animal bonds strengthen, pet owners are more attuned to their companions' health needs, prompting a surge in demand for specialized diets.

Obesity remains the most prevalent chronic condition in pets. According to the 2022 U.S. Pet Obesity Prevalence Survey, 59% of dogs and 61% of cats were classified as overweight or obese. This marks an increase from previous years, highlighting a persistent upward trend in pet obesity rates. Obesity in pets is associated with various health complications, including diabetes, osteoarthritis, and cardiovascular diseases. For instance, obese cats are 2-4 times more likely to develop diabetes mellitus. These conditions necessitate specialized therapeutic diets to manage and mitigate associated risks.

Diabetes is another prevalent chronic condition in pets, particularly among obese cats. The majority of diabetic cats suffer from Type 2 diabetes or insulin resistance, conditions closely linked to obesity. Managing diabetes in pets requires precise dietary control to regulate blood glucose levels and prevent complications.

Chronic Kidney Disease is a common ailment in aging pets, especially cats. The condition leads to a gradual decline in kidney function, necessitating dietary adjustments to manage symptoms and slow progression. Therapeutic diets formulated for CKD typically feature controlled protein levels, enhanced palatability, and increased moisture content to support kidney health.

Gastrointestinal disorders, such as inflammatory bowel disease (IBD), are prevalent in both dogs and cats. These conditions cause chronic inflammation of the gastrointestinal tract, leading to symptoms like vomiting, diarrhea, and weight loss. Therapeutic diets for gastrointestinal disorders often include novel protein sources, prebiotics, and fiber to support digestive health and reduce inflammation.

The escalating prevalence of chronic health conditions in pets underscores the need for specialized therapeutic diets. As pet owners become more proactive in managing their pets' health, the demand for tailored nutritional solutions is poised to continue its upward trajectory, driving growth in the pet therapeutic diet market.

Key Market Challenges

High Cost of Therapeutic Diets

One of the most pressing challenges in the global pet therapeutic diet market is the relatively high cost of these specialized products compared to standard pet foods. Therapeutic diets are formulated using high-quality, condition-specific ingredients designed to manage chronic health issues in pets, such as obesity, diabetes, kidney disease, and gastrointestinal disorders. These ingredients, which often include hydrolyzed proteins, novel proteins, fiber blends, and functional additives, are typically more expensive than conventional pet food ingredients. Additionally, research and development costs associated with creating scientifically validated diets contribute to the premium pricing of these products.

The elevated cost of therapeutic diets poses a barrier to adoption for many pet owners, particularly in price-sensitive markets. While pet owners recognize the health benefits of these specialized diets, sustaining long-term use can be financially challenging, especially for pets that require lifelong dietary management. For example, a dog or cat diagnosed with chronic kidney disease may need a therapeutic diet for several years, resulting in significant cumulative expenses. In regions where disposable income is lower or where pet insurance coverage is limited, the high cost can deter pet owners from choosing therapeutic diets, leading to reliance on standard pet foods or alternative solutions.

The premium pricing also affects repeat purchase behavior. Even if pet owners initially invest in therapeutic diets, affordability concerns may result in inconsistent feeding or early discontinuation, reducing the efficacy of the diet and potentially slowing market growth. To overcome this challenge, manufacturers are exploring strategies such as offering smaller packaging, subscription-based models, and region-specific pricing to make therapeutic diets more accessible without compromising quality. Addressing the cost barrier is essential for wider market penetration and long-term growth in the global pet therapeutic diet segment.

Key Market Trends

Integration of Functional Ingredients

The integration of functional ingredients into pet therapeutic diets is emerging as a pivotal trend in the global market, reflecting pet owners' growing focus on overall health and wellness. Beyond addressing specific health conditions, modern pet owners increasingly demand diets that provide additional health benefits, such as supporting digestive health, improving skin and coat quality, and enhancing cognitive function. To meet these needs, manufacturers are incorporating scientifically backed functional ingredients such as probiotics, prebiotics, omega-3 fatty acids, antioxidants, and fiber blends into therapeutic formulations.

Probiotics, for instance, have become a cornerstone of gastrointestinal support in both cats and dogs. By introducing beneficial bacteria into the gut, probiotics help maintain a balanced microbiome, which can improve nutrient absorption, reduce gastrointestinal discomfort, and support immune function. Veterinary experts note that while the canine and feline microbiomes are less studied than those of humans, evidence suggests that probiotics can assist with conditions like acute diarrhea, inflammatory bowel disease, and even weight management in pets. Similarly, prebiotics serve as dietary fibers that nourish these beneficial bacteria, enhancing their effectiveness and supporting overall gut health.

In addition to digestive benefits, omega-3 fatty acids and antioxidants play crucial roles in systemic health. Omega-3s, such as EPA and DHA, contribute to cardiovascular health, reduce inflammation, and support skin and coat condition. Antioxidants like vitamins C and E help neutralize free radicals, supporting cellular health and potentially improving cognitive function in aging pets.

The inclusion of these functional ingredients has positioned therapeutic diets as more than just medical foods, they are now seen as comprehensive health solutions. By addressing multiple aspects of wellness simultaneously, these diets not only manage chronic conditions but also promote preventive care, ultimately increasing adherence among pet owners and driving sustained market growth.

Key Market Players

• Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
• Nestle S.A.
• Mars, Incorporated
• General Mills Inc. (Blue Buffalo Company, Ltd.)
• SCHELL & KAMPETER, INC. (DIAMOND PET FOODS)
• Virbac Corporation
• Veterinary Nutrition Group Pty Ltd
• Farmina Pet Foods
• JustFoodForDogs
• EmerAid, LLC

Report Scope

In this report, the Global Pet Therapeutic Diet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pet Therapeutic Diet Market, By Product:

• Wet Food
• Dry Food
• Others

Pet Therapeutic Diet Market, By Animal Type:

• Dogs
• Cats
• Others

Pet Therapeutic Diet Market, By Indication:

• Renal Care
• Obesity Care
• Diabetic Care
• Dental Care
• Gastrointestinal Care
• Recovery Care
• Others

Pet Therapeutic Diet Market, By Distribution Channel:

• E-commerce
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Others

Pet Therapeutic Diet Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pet Therapeutic Diet Market.

Available Customizations:

Global Pet Therapeutic Diet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pet Therapeutic Diet Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Wet Food, Dry Food, Others)
  • 5.2.2. By Animal Type (Dogs, Cats, Others)
  • 5.2.3. By Indication (Renal Care, Obesity Care, Diabetic Care, Dental Care, Gastrointestinal Care, Recovery Care, Others)
  • 5.2.4. By Distribution Channel (E-commerce, Veterinary Hospitals & Clinics, Retail Pharmacies, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Pet Therapeutic Diet Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Animal Type
  • 6.2.3. By Indication
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pet Therapeutic Diet Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Animal Type
      • 6.3.1.2.3. By Indication
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Mexico Pet Therapeutic Diet Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Animal Type
      • 6.3.2.2.3. By Indication
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Canada Pet Therapeutic Diet Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Animal Type
      • 6.3.3.2.3. By Indication
      • 6.3.3.2.4. By Distribution Channel

7. Europe Pet Therapeutic Diet Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Animal Type
  • 7.2.3. By Indication
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pet Therapeutic Diet Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Animal Type
      • 7.3.1.2.3. By Indication
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. Germany Pet Therapeutic Diet Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Animal Type
      • 7.3.2.2.3. By Indication
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Pet Therapeutic Diet Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Animal Type
      • 7.3.3.2.3. By Indication
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Pet Therapeutic Diet Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Animal Type
      • 7.3.4.2.3. By Indication
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Pet Therapeutic Diet Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Animal Type
      • 7.3.5.2.3. By Indication
      • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Pet Therapeutic Diet Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Animal Type
  • 8.2.3. By Indication
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pet Therapeutic Diet Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Animal Type
      • 8.3.1.2.3. By Indication
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Pet Therapeutic Diet Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Animal Type
      • 8.3.2.2.3. By Indication
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. South Korea Pet Therapeutic Diet Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Animal Type
      • 8.3.3.2.3. By Indication
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. Japan Pet Therapeutic Diet Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Animal Type
      • 8.3.4.2.3. By Indication
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Pet Therapeutic Diet Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Animal Type
      • 8.3.5.2.3. By Indication
      • 8.3.5.2.4. By Distribution Channel

9. South America Pet Therapeutic Diet Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Animal Type
  • 9.2.3. By Indication
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pet Therapeutic Diet Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Animal Type
      • 9.3.1.2.3. By Indication
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Pet Therapeutic Diet Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Animal Type
      • 9.3.2.2.3. By Indication
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Pet Therapeutic Diet Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Animal Type
      • 9.3.3.2.3. By Indication
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Pet Therapeutic Diet Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Animal Type
  • 10.2.3. By Indication
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pet Therapeutic Diet Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Animal Type
      • 10.3.1.2.3. By Indication
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Pet Therapeutic Diet Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Animal Type
      • 10.3.2.2.3. By Indication
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Pet Therapeutic Diet Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Animal Type
      • 10.3.3.2.3. By Indication
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pet Therapeutic Diet Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Service Offerings
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Nestle S.A.
• 15.3. Mars, Incorporated
• 15.4. General Mills Inc. (Blue Buffalo Company, Ltd.)
• 15.5. SCHELL & KAMPETER, INC. (DIAMOND PET FOODS)
• 15.6. Virbac Corporation
• 15.7. Veterinary Nutrition Group Pty Ltd
• 15.8. Farmina Pet Foods
• 15.9. JustFoodForDogs
• 15.10. EmerAid, LLC

16. Strategic Recommendations

17. About Us & Disclaimer